MedPath

Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals

Not Applicable
Completed
Conditions
Bread
Hematologic Tests
Dietary Modification
Gastrointestinal Microbiome
Body Weight Changes
Registration Number
NCT02936362
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

Bread is the most common grain product in the world, with consumption surpassing 3 billion individuals per year. Sourdough whole-grain bread is considered a healthy alternative to white, refined-wheat bread.

This cross-over study will test the effect of consumption of sourdough bread compared to white bread following a short dietary intervention period (one week) on multiple clinical parameters and gut microbiota.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Able to provide and signed informed consent form
  • Over 18 years
  • Not in active military service
  • Ability to technically operate a glucometer
Exclusion Criteria
  • Prediagnosed type I / type II diabetes mellitus
  • Pregnancy
  • Usage of antibiotics within three months prior to participation
  • Chronically active inflammatory or neoplastic disease in the three years prior to enrollment
  • Skin disease, including contact dermatitis, precluding proper attachment of the continuous glucose monitor

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Changes to glycemic controlOne week

Measured as blood glucose levels at wake-up (mg/dl).

Secondary Outcome Measures
NameTimeMethod
Changes to triglycerides levels (mg/dl)One week

Measured by a blood test.

Changes to Creatinine levels (mg/dl)One week

Measured by a blood test.

Changes to LDL cholesterol levels (mg/dl)One week

Measured by a blood test.

Changes to C-Reactive Protein (CRP) levels (mg/l)One week

Measured by a blood test.

Changes to weight (Kg.)One week
Changes to blood pressure (mmHg)One week
Changes to Alanine Transaminase (ALT) levels (IU/l)One week

Measured by a blood test.

Changes to Aspartate Transaminase (AST) levels (IU/I)One week

Measured by a blood test.

Changes to Gamma-Glutamyl Transpeptidase (GGT) levels (IU/l)One week

Measured by a blood test.

Changes to Urea levels (mg/dl)One week

Measured by a blood test.

Changes to total cholesterol levels (mg/dl)One week

Measured by a blood test.

Changes to HDL cholesterol levels (mg/dl)One week

Measured by a blood test.

Changes to Basal Metabolic Rate (BMR; J)One week
Changes to Magnesium levels (mg/dl)One week

Measured by a blood test.

Changes to Calcium levels (mg/dl)One week

Measured by a blood test.

Changes to Iron levels (mg/dl)One week

Measured by a blood test.

Changes to Lactate Dehydrogenase (LDH) levelsOne week

Measured by a blood test (IU/l)

Changes to Thyroid Stimulating Hormone (TSH)One week D

Measured by a blood test (mIU/ml)

Trial Locations

Locations (2)

Weizmann Institute of Science

🇮🇱

Rehovot, Israel

Department of Gastroentherology

🇮🇱

Tel Aviv, Israel

Weizmann Institute of Science
🇮🇱Rehovot, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.